NEW YORK (GenomeWeb) – Belgian chromatography firm PharmaFluidics is looking to make inroads into markets including proteomics and clinical research with its microchip-based liquid chromatography technology.

PharmaFluidics' LC system, called µPAC, uses patterned microchips for sample separation upfront of instrumentation like mass spectrometry. According to Katrien Vanhonacker, the company's vice president of business development and sales, the system offers advantages over conventional LC technology in terms of separation power, peak sharpness, and robustness and reproducibility.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.